Dipak Panigrahy Selected Research

Autacoids

1/2022	COVID-19 and cancer: start the resolution!
1/2021	Carcinogenesis: Failure of resolution of inflammation?
1/2020	Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
1/2019	Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases.
1/2018	Resolvins suppress tumor growth and enhance cancer therapy.
12/2011	EET signaling in cancer.
11/2011	Regulation of inflammation in cancer by eicosanoids.
12/2010	Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dipak Panigrahy Research Topics

Disease

37	Neoplasms (Cancer) 07/2022 - 10/2002
25	Inflammation (Inflammations) 07/2022 - 07/2005
8	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2002
7	Carcinogenesis 01/2021 - 05/2004
5	Cytokine Release Syndrome 10/2021 - 01/2020
4	Pathologic Neovascularization 07/2022 - 09/2010
4	Infections 01/2022 - 01/2020
3	COVID-19 01/2022 - 01/2020
3	Corneal Neovascularization 08/2013 - 01/2008
2	Thrombosis (Thrombus) 01/2022 - 01/2020
2	Hypersensitivity (Allergy) 01/2020 - 09/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2018
2	Retinal Neovascularization 03/2014 - 09/2010
2	Glioblastoma (Glioblastoma Multiforme) 10/2013 - 09/2010
1	Ischemia 10/2020
1	Fibrosis (Cirrhosis) 10/2020
1	Reperfusion Injury 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Pain (Aches) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Coronavirus Infections 01/2020
1	Fever (Fevers) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Pathologic Processes 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Neoplasm Micrometastasis 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Colitis 01/2018

Drug/Important Bio-Agent (IBA)

17	LipidsIBA 07/2022 - 12/2010
12	EicosanoidsIBA 10/2021 - 12/2010
10	Epoxide HydrolasesIBA 10/2021 - 01/2012
9	CytokinesIBA 01/2022 - 10/2012
8	AutacoidsIBA 01/2022 - 12/2010
6	Arachidonic Acid (Vitamin F)IBA 01/2021 - 12/2010
6	AcidsIBA 01/2020 - 04/2013
6	LigandsIBA 01/2019 - 10/2002
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2014 - 12/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 10/2002
4	LipoxinsIBA 07/2022 - 01/2019
4	ProstaglandinsIBA 01/2021 - 12/2010
4	EnzymesIBA 10/2014 - 11/2011
3	LeukotrienesIBA 01/2021 - 12/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 02/2012
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020 - 11/2011
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2014 - 02/2012
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2014 - 03/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2010 - 02/2007
2	CarcinogensIBA 01/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 07/2014
2	Pharmaceutical PreparationsIBA 01/2019 - 09/2010
2	Lipoxygenase (Lipoxygenase-1)IBA 10/2014 - 03/2014
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2014 - 09/2010
2	Oxygen (Dioxygen)IBA 03/2014 - 10/2012
2	Retinaldehyde (Retinal)IBA 03/2014 - 08/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2012 - 05/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 05/2004
2	CytochromesIBA 12/2011 - 12/2010
2	Rosiglitazone (Avandia)FDA Link 09/2010 - 10/2002
2	EndostatinsIBA 09/2010 - 01/2008
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2010 - 05/2008
2	Angiogenesis InhibitorsIBA 09/2010 - 02/2007
2	PPAR alphaIBA 01/2008 - 02/2007
2	PPAR gammaIBA 07/2005 - 10/2002
1	Dinoprostone (PGE2)FDA Link 10/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	AsbestosIBA 01/2021
1	NitrosaminesIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	AflatoxinsIBA 01/2021
1	Enalapril FDA LinkGeneric 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	Antihypertensive Agents (Antihypertensives)IBA 10/2020
1	ThromboxanesIBA 01/2020
1	Environmental CarcinogensIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Aflatoxin B1 (Aflatoxin B)IBA 01/2020
1	taxaneIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	ChemokinesIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	KetorolacIBA 01/2019
1	OsteopontinIBA 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	PlatinumIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2018
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	PhosphatidylserinesIBA 01/2018
1	resolvin D1IBA 01/2018

Therapy/Procedure

19	Therapeutics 01/2022 - 12/2003
9	Drug Therapy (Chemotherapy) 11/2021 - 09/2010
1	Aftercare (After-Treatment) 01/2022